Vivos Therapeutics (VVOS.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Vivos’ mmRNA (modified mandibular Repositioning Nighttime Appliance) device, not to be…
dental equipment
BIOLASE Inc. (BIOL.Q) has announced its Q2 2021 Financial Results for the quarter ended June 30, 2021 and has provided Q3 2021 revenue guidance. “Our focus on educating and…